Movano (NASDAQ:MOVE – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.
Volatility and Risk
Movano has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500.
Profitability
This table compares Movano and KORU Medical Systems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Movano | -3,409.60% | -647.91% | -225.03% |
| KORU Medical Systems | -9.49% | -22.43% | -13.86% |
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Movano | 1 | 0 | 0 | 0 | 1.00 |
| KORU Medical Systems | 1 | 1 | 3 | 1 | 2.67 |
KORU Medical Systems has a consensus price target of $5.88, indicating a potential downside of 5.70%. Given KORU Medical Systems’ stronger consensus rating and higher possible upside, analysts plainly believe KORU Medical Systems is more favorable than Movano.
Earnings & Valuation
This table compares Movano and KORU Medical Systems”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Movano | $1.01 million | 6.69 | -$23.73 million | ($10.83) | -0.75 |
| KORU Medical Systems | $39.07 million | 7.39 | -$6.07 million | ($0.08) | -77.88 |
KORU Medical Systems has higher revenue and earnings than Movano. KORU Medical Systems is trading at a lower price-to-earnings ratio than Movano, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
16.6% of Movano shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 10.4% of Movano shares are owned by company insiders. Comparatively, 20.6% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
KORU Medical Systems beats Movano on 13 of the 15 factors compared between the two stocks.
About Movano
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.
